CIK 0001773751
- Large accelerated filer
Hims & Hers Health, Inc.
Sign in to watch- Ticker
- HIMS
- Exchange
- NYSE
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 415-851-0195
- Business address
- 2269 CHESTNUT ST, #523, SAN FRANCISCO, CA, 94123
- Former names
- Oaktree Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,483,933
- in 10 filings, $2.5M under 10b5-1 plans
Net −$2,483,933. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-08-18 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −47,534 | $45.05 | $2.1M | 142,592 |
| 2025-08-18 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −2,792 | $44.97 | $126K | 89,521 |
| 2025-08-18 | Dudum Andrew Chief Executive Officer | Exercise or conversion 10b5-1 | +17,001 | $2.43 | $41K | 106,522 |
| 2025-08-18 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −17,001 | $45.14 | $767K | 89,521 |
| 2025-08-18 | Dudum Andrew Chief Executive Officer | Exercise or conversion 10b5-1 | +108,334 | $2.43 | $263K | 197,855 |
| 2025-08-18 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −41,667 | $45.11 | $1.9M | 156,188 |
| 2025-08-18 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −50,000 | $45.04 | $2.3M | 106,188 |
| 2025-08-18 | Dudum Andrew Chief Executive Officer | Sale 10b5-1 | −16,667 | $44.92 | $749K | 89,521 |
| 2025-08-18 | Dudum Andrew Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −17,001 | 51,007 | ||
| 2025-08-18 | Dudum Andrew Chief Executive Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −108,334 | 648,063 | ||
| 2025-08-13 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion 10b5-1 | +11,581 | $5.01 | $58K | 65,665 |
| 2025-08-13 | Okupe Oluyemi Chief Financial Officer | Sale 10b5-1 | −11,581 | $48.05 | $556K | 116,806 |
| 2025-08-13 | Okupe Oluyemi Chief Financial Officer | Exercise or conversion · Stock Option (right to buy) 10b5-1 | −11,581 | 361,365 | ||
| 2025-08-11 | Boughton Soleil Chief Legal Officer | Sale 10b5-1 | −2,572 | $51.64 | $133K | 153,021 |
| 2025-08-07 | Dudum Andrew Chief Executive Officer | Sale | −660,000 | $50.58 | $33.4M | 2,214,769 |
| 2025-08-06 | WELLS DAVID B Director | Grant or award · Restricted Stock Unit | +3,656 | 3,656 | ||
| 2025-08-06 | Payne Christopher D Director | Grant or award · Restricted Stock Unit | +3,656 | 3,656 | ||
| 2025-08-06 | Perez Garcia Andrea G Director | Grant or award · Restricted Stock Unit | +3,656 | 3,656 | ||
| 2025-08-06 | Cosgrove Delos M. Director | Grant or award · Restricted Stock Unit | +3,656 | 3,656 | ||
| 2025-08-06 | Autor Deborah M. Director | Grant or award · Restricted Stock Unit | +3,656 | 3,656 |
Page 26 of 37 · 739 trades